Guest guest Posted April 5, 2011 Report Share Posted April 5, 2011 A new screening technology should lead to rapid identification of compounds that can turn on tumor silencing genes ... already implicated in contributing to the bad behavior of lymphoma cells when restricted by enzymes. " The method was efficient enough to permit screening of the entire genome, including 21,122 genes, and revealed 128 factors that are involved in regulating gene expression. " http://www.sciencedaily.com/releases/2011/04/110405082620.htm Comment: A few such compounds have already achieve marketing approval for the treatment of lymphoma, such as SAHA and Romidepsin All the best, ~ Karl Patients Against Lymphoma Patients Helping Patients How to Help: www.lymphomation.org/how-to-help.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.